Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pancuronium pandemonium as doctors slam Hospira for execution injections

This article was originally published in Scrip

Executive Summary

An open letter published in the Lancet has criticised Hospira for its handling of the use of its muscle relaxant pancuronium bromide in executions in the US. However, Lundbeck, which faced a similar issue with its drug pentobarbital (Nembutal) for acute convulsive disorders, has emerged with its reputation intact. The letter praises the firm for its "truly exemplary" response to the situation after it tightened distribution of the drug.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts